- Home
- WYY vs COYA Comparison
WYY vs COYA Comparison
Compare WYY & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYY | COYA |
|---|---|---|
| Founded | 1991 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.3M | 102.7M |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WYY | COYA |
|---|---|---|
| Price | $6.77 | $3.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.21 |
| AVG Volume (30 Days) | ★ 406.3K | 114.0K |
| Earning Date | 08-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $150,545,364.00 | $7,945,753.00 |
| Revenue This Year | $12.26 | N/A |
| Revenue Next Year | $25.66 | $387.14 |
| P/E Ratio | $649.00 | ★ N/A |
| Revenue Growth | 5.59 | ★ 123.57 |
| 52 Week Low | $3.96 | $3.71 |
| 52 Week High | $24.30 | $6.77 |
Technical Indicators
Market Signals| Indicator | WYY | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 31.34 |
| Support Level | $4.34 | $3.89 |
| Resistance Level | $7.49 | $5.17 |
| Average True Range (ATR) | 0.41 | 0.29 |
| MACD | 0.09 | -0.07 |
| Stochastic Oscillator | 71.35 | 2.34 |
Price Performance
Historical ComparisonAbout WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.